Operating Lease, Right-of-Use Asset of FibroBiologics, Inc. from 31 Dec 2022 to 31 Dec 2025

Taxonomy & unit: us-gaap: USD
Description: Amount of lessee's right to use underlying asset under operating lease.
Summary: FibroBiologics, Inc. quarterly Operating Lease, Right-of-Use Asset in USD history and change rate from 31 Dec 2022 to 31 Dec 2025.
FibroBiologics, Inc. Operating Lease, Right-of-Use Asset for the quarter ending 31 Dec 2025 was $2,380,000, a 71% increase year-over-year.
Source SEC data: View on sec.gov

Operating Lease, Right-of-Use Asset, Quarterly (USD)

Operating Lease, Right-of-Use Asset, YoY Quarterly Change (%)

FibroBiologics, Inc. Quarterly Operating Lease, Right-of-Use Asset (USD)

Period	Value	YoY Chg	Change %	Date	Report	Filed	Fiscal Year	Fiscal Period
Q4 2025	$2,380,000	+$987,000	+71%	31 Dec 2025	10-K	24 Feb 2026	2025	FY
Q3 2025	$2,548,000	+$1,049,000	+70%	30 Sep 2025	10-Q	31 Oct 2025	2025	Q3
Q2 2025	$2,714,000	+$1,110,000	+69%	30 Jun 2025	10-Q	31 Jul 2025	2025	Q2
Q1 2025	$1,285,000	-$422,000	-25%	31 Mar 2025	10-Q	14 May 2025	2025	Q1
Q4 2024	$1,393,000	-$416,000	-23%	31 Dec 2024	10-K	24 Feb 2026	2025	FY
Q3 2024	$1,499,000			30 Sep 2024	10-Q	12 Nov 2024	2024	Q3
Q2 2024	$1,604,000			30 Jun 2024	10-Q	07 Aug 2024	2024	Q2
Q1 2024	$1,707,000			31 Mar 2024	10-Q	14 May 2024	2024	Q1
Q4 2023	$1,809,000	-$390,000	-18%	31 Dec 2023	10-K	31 Mar 2025	2024	FY
Q4 2022	$2,199,000			31 Dec 2022	10-K	29 Feb 2024	2023	FY

* An asterisk sign (*) next to the value indicates that the value is likely invalid.